Serum stem cell growth factor for monitoring hematopoietic recovery following stem cell transplantation

Bone Marrow Transplantation

Volumn 32, Issue 4, 2003, Pages 391-398

  Ito, C ^a   Sato, H ^b   Ando, K ^a   Watanabe, S ^a   Yoshiba, F ^a   Kishi, K ^a   Furuya, A ^b   Shitara, K ^b   Sugimoto, S ^b   Kohno, H ^c   Hiraoka, A ^d   Hotta, T ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

^c Kyowa Medex Co Ltd   (Japan)

^d OSAKA DENTAL UNIVERSITY   (Japan)

Author keywords

Cytokines; Hematopoiesis; Indicator; Stem cell growth factor; Stem cell transplantation

Indexed keywords

CARBOPLATIN; CD33 ANTIGEN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; CYTOKINE; DEXAMETHASONE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH FACTOR; MELPHALAN; RANIMUSTINE;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; APLASTIC ANEMIA; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CELL ACTIVITY; CELL POPULATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL OBSERVATION; COLONY FORMING CELL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT VERSUS HOST REACTION; GRANULOCYTE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MONITORING; MOUSE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; VOLUNTEER; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT VS HOST DISEASE; GRANULOCYTES; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HEMATOPOIETIC SYSTEM; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-6; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL FACTOR; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION CONDITIONING;

EID: 10744233883     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704152     Document Type: Article

References (18)

1. Hiraoka A, Sugimura A, Seki T et al. Cloning, expression, and characterization of a cDNA encoding a novel human growth factor for primitive hematopoietic progenitor cells. Proc Natl Acad Sci USA 1997; 94: 7577-7582.
2. Hiraoka A, Ohkubo T, Fukuda M. Production of human hematopoietic survival and growth factor by a myeloid leukemia cell line (KPB-M15) and placenta as detected by a monoclonal antibody. Cancer Res 1987; 47: 5025-5030.
3. Hiraoka A, Yano K, Kagami N et al. Stem cell growth factor: in situ hybridization analysis on the gene expression, molecular characterization and in vitro proliferative activity of a recombinant preparation on primitive hematopoietic progenitor cells. Hematol J 2001; 2: 307-315.
4. Weinthal JA. The role of cytokines following bone marrow transplantation: indications and controversies. Bone Marrow Transplant 1996; 18 (Suppl. 3): S10-S14.
5. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993; 81: 2844-2853.
6. Rowbottom AW, Riches PG, Downie C, Hobbs JR. Monitoring cytokine production in peripheral blood during acute graft-versus-host disease following allogeneic bone marrow transplantation. Bone Marrow Transplant 1993; 12: 635-641.
7. Imamura M, Hashino S, Kobayashi H et al. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease. Bone Marrow Transplant 1994; 13: 745-751.
8. Cairo MS, Gillan ER, Weinthal J et al. Decreased endogenous circulating steel factor (SLF) levels following allogeneic and autologous BMT: lack of an inverse correlation with post-BMT myeloid engraftment. Bone Marrow Transplant 1993; 11: 155-161.
9. Weisdorf DJ, DeFor T, Nichol J et al. Thrombopoietic cytokines in relation to platelet recovery after bone marrow transplantation. Bone Marrow Transplant 2000; 25: 711-715.
10. Hamaguchi M, Yamada H, Morishima Y et al. Serum thrombopoietin level after allogeneic bone marrow transplantation: possible correlations with platelet recovery, acute graft-versus-host disease and hepatic veno-occlusive disease. Nagoya Bone Marrow Transplantation Group. Int J Hematol 1996; 64: 241-248.
11. Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495-497.
12. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
13. Takatsuka H, Takemoto Y, Yamada S et al. Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome. Bone Marrow Transplant 2000; 26: 419-426.
14. Molineux G, McNiece LK. Stem cell factor. In: Angus WT (ed.). The cytokine handbook. Academic Press: California, 1998, pp 713-725.
15. David JK. Thrombopoietin. In: Joost JO, Marc F(eds.). Cytokine reference. Academic Press: California, 2001, pp, 965-982.
16. Rusten LS, Lyman SD, Veuby OP et al. The FLT3 ligand is a direct and potent stimulator of the growth of primitive and committed human CD34+ bone marrow progenitor cells in vitro. Blood 1996; 87: 1317-1325.
17. Steffen M, Pichlmeier U, von dem Busche C, Zander A. Serum levels of stem cell factor in patients during transplantation of bone marrow or peripheral blood stem cells. J Hematother Stem Cell Res 2000; 9: 55-61.
18. Steffen M, Durken M, Pichlmeier U et al. Serum interleukin-6 levels during bone marrow transplantation: impact on transplant-related toxicity and engraftment. Bone Marrow Transplant 1996; 18: 301-307.